Nelsen Robert

Sana Biotechnology, Inc. · Director, 10% Owner

Nelsen Robert is listed in public filings as director, 10 percent owner:. This Nelsen Robert insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Sana Biotechnology, Inc. (SANA), Prime Medicine, Inc. (PRME), and Lyell Immunopharma, Inc. (LYEL). Investors use Nelsen Robert's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Sana Biotechnology, Inc.SANA$266k90k sharesGrant / ExerciseJun 4, 2026$266.4K90k shares$2.96--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Prime Medicine, Inc.PRME$21M6.2M sharesBuyAug 1, 2025$10.0M3M shares$3.30--
Prime Medicine, Inc.PRME$039.1k sharesOtherAug 1, 2025$579.3K39.1k shares$14.83--
Prime Medicine, Inc.PRME$045k sharesOtherAug 1, 2025$345.6K45k shares$7.68--
Prime Medicine, Inc.PRME$182k45k sharesGrant / ExerciseAug 1, 2025$181.8K45k shares$4.04--
Prime Medicine, Inc.PRME$158k39.1k sharesGrant / ExerciseAug 1, 2025$157.8K39.1k shares$4.04--
Sana Biotechnology, Inc.SANA$204k80k sharesGrant / ExerciseJun 5, 2025$204.0K80k shares$2.55--
Prime Medicine, Inc.PRME$73k55k sharesGrant / ExerciseJun 4, 2025$72.6K55k shares$1.32--
Lyell Immunopharma, Inc.LYEL$307k130k sharesGrant / ExerciseJun 14, 2024$306.8K130k shares$2.36--
Prime Medicine, Inc.PRME$346k45k sharesGrant / ExerciseJun 12, 2024$345.6K45k shares$7.68--